Dáil Éireann Debate, Tuesday - 20 November 2018
417. Deputy James Browne asked the Minister for Health the number of drugs considered by the rare disease technology review committee; the names of the drugs; and if he will make a statement on the matter. [47997/18]
Amharc ar fhreagraThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicines, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
